RecruitingNCT07100288
Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer
Sponsor
Complejo Hospitalario Universitario Insular Materno Infantil
Enrollment
200 participants
Start Date
Jul 20, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria5
- ◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.
- FIGO 2014 stage IA-IVB.
- Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy
- Patients with no residual disease after surgery.
- Patients with ECOG performance status 0-1.
Exclusion Criteria4
- ◦ Patients without epithelial ovarian cancer.
- Patients with ECOG 2-4.
- Patients who do not consent to participate in the study.
- Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.
Interventions
OTHERresection of infundibulopelvic ligament
Therefore, this study also aims to perform bilateral infundibulopelvic ligament resection (at least 8 cm in length) during surgery for ovarian cancer patients
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07100288
Related Trials
Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology
NCT071674331 location
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
NCT074245475 locations
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
NCT064125101 location
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT0465706879 locations